A. Kawakami et al., EXPRESSION AND FUNCTION OF FAS AND FAS LIGAND ON PERIPHERAL-BLOOD LYMPHOCYTES IN NORMAL SUBJECTS, The Journal of laboratory and clinical medicine, 132(5), 1998, pp. 404-413
Citations number
41
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental","Medical Laboratory Technology
We investigated the expression and function of Pas and Pas ligand (Fas
L) on peripheral blood lymphocytes (PBLs). The cells were stimulated w
ith various cytokines or 12-O-tetradecanoyl phorbol 13-acetate (PMA) p
lus ionomycin, About 30% of unstimulated PBLs expressed Fas, and the e
xpression was augmented by interleukin-1 beta (IL-1 beta), IL-2, tumor
necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), or P
MA plus ionomycin, Although only minimal Past expression was detected
on unstimulated PBLs, Fast expression was markedly induced by IL-2 or
PMA plus ionomycin, suggesting that Pas and Past were both expressed o
n IL-2-stimulated or PMA-plus-ionomycin-stimulated PBLs. Although Ii-2
-stimulated or PMA-plus-ionomycln-stimulated PBLs were positive for bo
th Fas and FasL, no significant increase in apoptosis was demonstrated
in these activated PBLs, In addition, treatment of PBLs with IL-2 or
PMA plus ionomycin did not change anti-Pas-induced apoptosis, although
these activated PBLs expressed Pas strongly when compared with unstim
ulated PBLs. Only IL-2-stimulated or PMA-plus-ionomycin-stimulated PBL
s killed Fas(+) target cells efficiently via the interaction of Pas on
target cells with Fas(+) of PBLs. Bcl-2 was constitutively expressed
on unstimulated PBLs, but its expression was significantly augmented b
y IL-2 or PMA plus ionomycin. The expression of Bar was clearly induce
d only on Ii-2-stimulated or PMA-plus-ionomycin-stimulated PBLs and th
at of other Bcl-2 family proteins such as Bcl-x and Bad could not be d
etected on human PBLs, including IL-2-stimulated or PMA-plus-ionomycin
-stimulated PBLs, Our results suggest that PBLs activated by IL-2 or P
MA plus ionomycin express both Pas and Fast and that they kill Fas(+)
target cells by using Fast on the surface, The resistance of these act
ivated PBLs to Pas-mediated apoptosis may be due to the augmented Bcl-
2 expression or the presence of Bcl-5:Bax heterodimers on these cells.